Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.10 (0.44%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £234.54m
SCLP Live PriceLast checked at - London Stock Exchange

Intraday Scancell Holdings Share Chart

Scancell Holdings News

N4 Pharma Appoints John Chiplin as Non-Executive Chairman
21 May 2019

N4 Pharma Appoints John Chiplin as Non-Executive Chairman

LONDON (Alliance News) - N4 Pharma PLC on Tuesday said it appointed John Chiplin as non-executive chair of the company with immediate effect.Furthermo...

Scancell partnership with Cancer Research moves closer to clinic
20 May 2019

Scancell partnership with Cancer Research moves closer to clinic

(Sharecast News) - Immunotherapy developer Scancell Holdings updated the market on its clinical development partnership with Cancer Research UK for th...

Scancell Says Cancer Vaccine SCIB2 Will Be Given Using New Formulation
20 May 2019

Scancell Says Cancer Vaccine SCIB2 Will Be Given Using New Formulation

LONDON (Alliance News) - Scancell Holdings PLC said Monday cancer vaccine SCIB2 is to be administered using a new nanoparticle formulation in an early...

Scancell Creates Advisory Board And Prepares For Drug Trials
10 May 2019

Scancell Creates Advisory Board And Prepares For Drug Trials

LONDON (Alliance News) - Scancell Holdings PLC on Friday said it has established a clinical advisory board and has begun manufacturing and toxicity te...

Scancell gets go-ahead for UK second phase trials of 'SCIB1'
25 Apr 2019

Scancell gets go-ahead for UK second phase trials of 'SCIB1'

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to ini...

Scancell Holdings expands IP protection with Japanese patent
8 Apr 2019

Scancell Holdings expands IP protection with Japanese patent

(Sharecast News) - Scancell Holdings on Monday won a Japanese patent for its Moditope immunotherapy platform, which stimulates the production of cells...

Scancell Gets Japan Patent Protecting Moditope Immunotherapy Platform
8 Apr 2019

Scancell Gets Japan Patent Protecting Moditope Immunotherapy Platform

LONDON (Alliance News) - Scancell Holdings PLC on Monday said the Japanese Patent Office has granted a patent providing protection for its Moditope im...

Scancell Holdings Gets Further Patent Protection In US And Europe
20 Mar 2019

Scancell Holdings Gets Further Patent Protection In US And Europe

LONDON (Alliance News) - Immunotherapy firm Scancell Holdings PLC has received a new patent for its Modi-1 drug candidate in the US, it said on Wednes...